ESP-31015
ESP-31015 (ETC-1001) is an orally active and non-fibrate based PPARα agonists. ESP-31015 demonstrates significant lipid-regulating effects in the obese Zucker rat model. ESP-31015 can be used in cardiovascular disease research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 413624-55-2
- 화학식: C17H34O3
- 분자량:286.45
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
제품 설명
IC50 & Target
[1]|
PPARα |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Hepatocyte | IC50 |
1.5 μM
Compound: 39
|
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
Inhibition of lipid synthesis in primary rat hepatocytes by incorporation radiolabeled acetate into cellular lipids
|
[PMID: 16392818] |
| Hepatocyte | IC50 |
4 μM
Compound: 14c
|
Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes
Concentration required for inhibition of lipid synthesis in primary cultures of rat hepatocytes
|
[PMID: 15537362] |
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female obese Zucker fatty rats model[1]
-
Dosage:100 mg/kg
-
Administration:Oral administration (p.o.), once daily for 2 weeks
-
Result:Showed a 34.6% increase in serum HDL-cholesterol and a 71% reduction in serum triglycerides.
Chemical Information
-
CAS No. 413624-55-2
-
분자량 286.45
-
화학식 C17H34O3
-
SMILES
OCC(C)(C)CCCCC(CCCCC(C)(C)CO)=O
-
Synonyms
ETC-1001
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)